广泛耐药结核病的治疗结果 - Suppr

Suppr

超能文献

Treatment outcomes in extensively resistant tuberculosis.

作者信息

Chan Edward D, Strand Matthew J, Iseman Michael D

出版信息

N Engl J Med. 2008 Aug 7;359(6):657-9. doi: 10.1056/NEJMc0706556.

DOI:10.1056/NEJMc0706556

PMID:18687654

Abstract

摘要

相似文献

Treatment outcomes in extensively resistant tuberculosis.

N Engl J Med. 2008 Aug 7;359(6):657-9. doi: 10.1056/NEJMc0706556.

Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.

Clin Infect Dis. 2008 Mar 15;46(6):958-9. doi: 10.1086/528875.

Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.

Clin Infect Dis. 2009 Mar 1;48(5):e50-2. doi: 10.1086/597010.

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8.

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.

J Antimicrob Chemother. 2009 Nov;64(5):1119-20. doi: 10.1093/jac/dkp344. Epub 2009 Sep 10.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.

Int J Tuberc Lung Dis. 2007 Sep;11(9):979-85.

State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.

Int J Tuberc Lung Dis. 2009 Nov;13(11):1319.

Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products.

Fitoterapia. 2009 Dec;80(8):453-60. doi: 10.1016/j.fitote.2009.07.010. Epub 2009 Aug 19.

Drug resistance in tuberculosis and options available.

J Indian Med Assoc. 2010 Feb;108(2):106-8.

引用本文的文献

Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China.

BMC Infect Dis. 2025 Sep 1;25(1):1086. doi: 10.1186/s12879-025-11491-4.

Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management.

Indian J Med Res. 2017 Mar;145(3):271-293. doi: 10.4103/ijmr.IJMR_177_16.

Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.

PLoS One. 2013 Jul 19;8(7):e68869. doi: 10.1371/journal.pone.0068869. Print 2013.

Trajectories of tuberculosis-specific interferon-gamma release assay responses among medical and nursing students in rural India.

J Epidemiol Glob Health. 2013 Jun;3(2):105-17. doi: 10.1016/j.jegh.2013.03.003. Epub 2013 Apr 10.

Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16004-11. doi: 10.1073/pnas.1214188109. Epub 2012 Sep 10.

Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes.

Cell Host Microbe. 2011 Jan 20;9(1):21-31. doi: 10.1016/j.chom.2010.12.004.

Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.

Pharmaceuticals (Basel). 2010 Jul 1;3(7):2268-2290. doi: 10.3390/ph3072268.

The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part I: the origins and nature of the problem.

Clin Transl Sci. 2008 Dec;1(3):249-54. doi: 10.1111/j.1752-8062.2008.00060.x.

Risk factors for MDR and XDR-TB in a tertiary referral hospital in India.

PLoS One. 2010 Mar 4;5(3):e9527. doi: 10.1371/journal.pone.0009527.

Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.

Curr Clin Pharmacol. 2010 May;5(2):96-114. doi: 10.2174/157488410791110797.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验